According to KOBAYASHI Pharmaceutical's latest financial reports the company has A$0.64 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | A$0.83 B | -29.19% |
2022-12-31 | A$1.17 B | -10.19% |
2021-12-31 | A$1.30 B | 9.87% |
2020-12-31 | A$1.18 B | 0.15% |
2019-12-31 | A$1.18 B | 11.58% |
2018-12-31 | A$1.06 B | 27.78% |
2017-12-31 | A$0.83 B | |
2016-03-31 | A$0.76 B | 10.94% |
2015-03-31 | A$0.68 B | 18.84% |
2014-03-31 | A$0.57 B | 20.13% |
2013-03-31 | A$0.48 B | -22.91% |
2012-03-31 | A$0.62 B | 25.48% |
2011-03-31 | A$0.49 B | 0.99% |
2010-03-31 | A$0.49 B | 18.22% |
2009-03-31 | A$0.41 B | 71.42% |
2008-03-31 | A$0.24 B | 5.96% |
2007-03-31 | A$0.23 B | -26.26% |
2006-03-31 | A$0.31 B | 29.54% |
2005-03-31 | A$0.24 B |